Search Results (537)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Molecular Targeted Therapy | Concept |
Why?
|
| Sabaawy, Hatim | Person |
Why?
|
| The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus. | Academic Article |
Why?
|
| The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumors. | Academic Article |
Why?
|
| Camidge, David | Person |
Why?
|
| Lieu, Christopher | Person |
Why?
|
| Bunn, Paul | Person |
Why?
|
| Integration of a Personalized Molecular Targeted Therapy into the Multimodal Treatment of Refractory Childhood Embryonal Tumor with Multilayered Rosettes (ETMR). | Academic Article |
Why?
|
| Non-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategies. | Academic Article |
Why?
|
| The evolution of combined molecular targeted therapies to advance the therapeutic efficacy in melanoma: a highlight of vemurafenib and cobimetinib. | Academic Article |
Why?
|
| The promise of molecular targeted therapies: protein kinase inhibitors in the treatment of cutaneous malignancies. | Academic Article |
Why?
|
| Activity of tarloxotinib-E in cells with EGFR exon-20 insertion mutations and mechanisms of acquired resistance. | Academic Article |
Why?
|
| Advances in Receptor-Targeted Radiolabeled Peptides for Melanoma Imaging and Therapy. | Academic Article |
Why?
|
| Bromodomain and extra-terminal?inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE. | Academic Article |
Why?
|
| Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017. | Academic Article |
Why?
|